We are live on ! Find out more
NVRO

NEVRO CORP.

Delisted

NVRO was delisted on the 2nd of April, 2025.

171 hedge funds and large institutions have $1.81B invested in NEVRO CORP. in 2018 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 62 increasing their positions, 46 reducing their positions, and 53 closing their positions.

New
Increased
Maintained
Reduced
Closed

82% more call options, than puts

Call options by funds: $29.9M | Put options by funds: $16.4M

35% more repeat investments, than reductions

Existing positions increased: 62 | Existing positions reduced: 46

11% less funds holding

Funds holding: 192171 (-21)

33% less capital invested

Capital invested by funds: $2.7B → $1.81B (-$883M)

38% less first-time investments, than exits

New positions opened: 33 | Existing positions closed: 53

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
171
Holders Change
-21
Holders Change %
-10.94%
% of All Funds
3.91%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
33
Increased
62
Reduced
46
Closed
53
Calls
$29.9M
Puts
$16.4M
Net Calls
+$13.4M
Net Calls Change
+$14.6M
Name Holding Trade Value Shares
Change
Change in
Stake
Teacher Retirement System of Texas
76
Teacher Retirement System of Texas
Texas
$1.56M -$142K -2,274 -8%
RhumbLine Advisers
77
RhumbLine Advisers
Massachusetts
$1.52M -$111K -1,768 -6%
UCFA
78
United Capital Financial Advisors
Texas
$1.52M
JRP
79
Jasper Ridge Partners
California
$1.48M
Ameriprise
80
Ameriprise
Minnesota
$1.41M -$2.59M -41,470 -63%
TD Asset Management
81
TD Asset Management
Ontario, Canada
$1.39M +$1.52M +24,363 New
ECM
82
Endurant Capital Management
California
$1.38M +$880K +14,075 +139%
ARTA
83
A.R.T. Advisors
New York
$1.27M +$1.39M +22,286 New
QT
84
Quantbot Technologies
New York
$1.26M +$1.33M +21,211 +2,386%
First Trust Advisors
85
First Trust Advisors
Illinois
$1.22M -$46.7K -747 -3%
TI
86
Trexquant Investment
Connecticut
$1.19M +$1.31M +20,882 New
DWT
87
Dorsey & Whitney Trust
South Dakota
$1.14M
AIG
88
American International Group
New York
$1.1M +$21.8K +349 +2%
UBS AM
89
UBS AM
Illinois
$1.08M +$34.1K +545 +3%
Man Group
90
Man Group
United Kingdom
$1.08M +$1.19M +19,003 New
PCM
91
Prelude Capital Management
New York
$1.08M +$766K +12,253 +184%
Manulife (Manufacturers Life Insurance)
92
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1.07M -$160K -2,561 -12%
PI
93
PEAK6 Investments
Illinois
$1.03M +$1.13M +18,065 New
GI
94
GAMCO Investors
Connecticut
$923K +$700K +11,200 +224%
Tudor Investment Corp
95
Tudor Investment Corp
Connecticut
$908K +$598K +9,564 +150%
MIH
96
Meitav Investment House
Israel
$902K -$413K -6,600 -30%
Russell Investments Group
97
Russell Investments Group
United Kingdom
$887K -$171K -2,735 -15%
State Board of Administration of Florida Retirement System
98
State Board of Administration of Florida Retirement System
Florida
$864K
MIM
99
MetLife Investment Management
New Jersey
$743K
VOYA Investment Management
100
VOYA Investment Management
Georgia
$661K

NVRO Hedge Fund Activity: Q3 2018 in Review

171 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in NEVRO CORP. (NVRO) for Q3 2018, worth a combined $1.81B — down 33% from $2.7B a quarter earlier.

Sellers outnumbered buyers: 53 funds closed out of NVRO and 33 opened new positions — a net loss of 20 holders — while 46 trimmed existing stakes and 62 added.

The largest buyer was Point72 Asset Management, adding an estimated $87.9M. The largest seller was Wells Fargo, cutting an estimated $72.2M.

  • 171 institutional investors held NEVRO CORP. (NVRO) as of Q3 2018, down from 192 in Q2 2018.
  • Funds reported $1.81B of NEVRO CORP. stock for Q3 2018, down 33% quarter-over-quarter.
  • 33 funds opened new NEVRO CORP. positions in Q3 2018 and 53 closed out, a net change of -20 holders.
  • The largest NEVRO CORP. buyer in Q3 2018 was Point72 Asset Management, an estimated $87.9M added.
  • The largest NEVRO CORP. seller in Q3 2018 was Wells Fargo, an estimated $72.2M sold.

Based on aggregated 13F filings for Q3 2018.